Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.130
-0.050 (-1.57%)
At close: May 13, 2026, 4:00 PM EDT
3.050
-0.080 (-2.56%)
After-hours: May 13, 2026, 7:42 PM EDT
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $13.23 million as of May 13, 2026. Its market cap has increased by 29.64% in one year.
Market Cap
13.23M
Enterprise Value
10.41M
1-Year Change
29.64%
Ranking
Category
Stock Price
$3.13
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $13.23M, a decrease of -93.16%. That is a compound annual growth rate of -31.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 13.23M | 173.65% |
| Dec 31, 2025 | 4.83M | -40.68% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genenta Science | 14.46M |
| Lexaria Bioscience | 14.30M |
| Ernexa Therapeutics | 14.01M |
| Vyome Holdings | 13.90M |
| BioLineRx | 13.50M |
| Intensity Therapeutics | 12.93M |
| Phio Pharmaceuticals | 12.78M |
| Psyence Biomedical | 12.77M |